Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2309012 | 0.86 | TSHR (0.41) | ACHETDP1TSHRCYP3A4TEAD4 | |
| SCHEMBL363120 | 0.82 | ACHE (0.52) | ACHETDP1ALDH1A1POLBMEN1 | |
| SCHEMBL20557364 | 0.81 | ACHE (0.41) | ACHETDP1TSHRCYP3A4TEAD4 | |
| SCHEMBL342740 | 0.81 | DRD2 (0.44) | ACHETDP1TSHRALDH1A1MAPT | |
| SCHEMBL28956767 | 0.79 | ACHE (0.39) | ACHETDP1TSHRCYP3A4TEAD4 | |
| SCHEMBL2602434 | 0.78 | ACHE (0.48) | ACHETDP1TSHRCYP3A4TEAD4 | |
| SCHEMBL21889 | 0.77 | CA1 (0.65) | ACHETDP1CYP3A4ALDH1A1MAPT | |
| SCHEMBL15744763 | 0.72 | ACHE (0.42) | ACHETDP1TSHRCYP3A4TEAD4 | |
| SCHEMBL452367 | 0.72 | MAPT (0.52) | TDP1TSHRALDH1A1POLBMAPT | |
| SCHEMBL83863 | 0.71 | TEAD4 (0.74) | ACHETDP1TSHRCYP3A4TEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12478615-B2 | Prolyl hydroxylase inhibitors and methods of use | AKEBIA THERAPEUTICS, INC. (US) | 2025-11-25 | — | — | US | claimed |
| CN-118922186-A | Novel compound and composition for preventing, alleviating or treating bacterial inflammation and inflammation-related disorder containing the same as active ingredient | 客融生物有限公司 | 2024-11-08 | — | — | CN | claimed |
| US-20240358691-A1 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | WARNER CHILCOTT COMPANY, LLC (PR) | 2024-10-31 | — | — | US | claimed |
| EP-3478792-B1 | CHEMILUMINESCENT SUBSTRATES | BECKMAN COULTER INC (US) | 2023-12-13 | — | — | EP | claimed |
| US-11495769-B2 | Inorganic light emitting diode and inorganic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2022-11-08 | — | — | US | claimed |
| US-20210167321-A1 | INORGANIC LIGHT EMITTING DIODE AND INORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-06-03 | — | — | US | claimed |
| US-10703971-B2 | Chemiluminescent substrates | BECKMAN COULTER, INC. (US) | 2020-07-07 | — | — | US | claimed |
| US-20190161675-A1 | CHEMILUMINESCENT SUBSTRATES | BECKMAN COULTER, INC. (US) | 2019-05-30 | — | — | US | claimed |
| EP-3478792-A1 | CHEMILUMINESCENT SUBSTRATES | Beckman Coulter Inc. (US) | 2019-05-08 | — | — | EP | claimed |
| EP-3122707-B1 | METHOD FOR COUPLING A FIRST AROMATIC COMPOUND TO A SECOND AROMATIC COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-04-25 | — | — | EP | claimed |
| EP-3149138-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| WO-2015184209-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150344817-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| EP-1351963-B1 | A PROCESS FOR THE SYNTHESIS OF ATORVASTATIN FORM V AND PHENYLBORONATES AS INTERMEDIATE COMPOUNDS | BIOCON LTD (IN) | 2010-08-18 | — | — | EP | claimed |
| US-6867306-B2 | Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds | BIOCON LIMITED (IN) | 2005-03-15 | — | — | US | claimed |
| US-20040072893-A1 | Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds | BIOCON INDIA LIMITED (IN) | 2004-04-15 | — | — | US | claimed |
| EP-1351963-A1 | A PROCESS FOR THE SYNTHESIS OF ATORVASTATIN FORM V AND PHENYLBORONATES AS INTERMEDIATE COMPOUNDS | Biocon India Limited (IN) | 2003-10-15 | — | — | EP | claimed |
| WO-2002057274-A1 | A PROCESS FOR THE SYNTHESIS OF ATORVASTATIN FORM V AND PHENYLBORONATES AS INTERMEDIATE COMPOUNDS | BIOCON INDIA LIMITED (IN) | 2002-07-25 | — | — | WO | claimed |
| WO-1995005081-A1 | BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS | U.S. BORAX INC. (US) | 1995-02-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358691-A1 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | HIF1AN, EGLN3, EGLN2 | ACHE 4874/4885TDP1 2317/4885TSHR 2646/4885 |
| US-12478615-B2 | Prolyl hydroxylase inhibitors and methods of use | HIF1AN, EGLN3, HIF1A | ACHE 4874/4885TDP1 1974/4885TSHR 2703/4885 |
| US-20040072893-A1 | Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds | HMGCR, DHCR7, GRHPR | ACHE 2113/4885TDP1 3752/4885TSHR 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.